Electrospun Silk Fibroin–Ce6 Films: Advancing Antibacterial Photodynamic Therapy

Study Background and Research Question

Chronic wound infections, particularly those caused by multidrug-resistant strains like Staphylococcus aureus, pose a persistent challenge in clinical management. Conventional antibiotic strategies are increasingly undermined by bacterial biofilm formation and resistance mechanisms, which hinder both treatment efficacy and healing outcomes. Silk fibroin, a natural biopolymer derived from silkworms, has established utility in tissue engineering due to its biocompatibility and ability to support cellular regeneration. However, native silk fibroin lacks intrinsic antibacterial properties, limiting its standalone application in infected wound care. To address this, the referenced study (Li et al., 2024) investigates whether integrating a photosensitizer—specifically, Chlorin e6 (Ce6)—into silk fibroin nanofiber scaffolds could simultaneously confer photodynamic antibacterial activity and promote tissue repair.

Key Innovation from the Reference Study

The core advancement reported by Li et al. is the fabrication of an aligned, electrospun silk fibroin nanofiber film conjugated with Ce6, termed SFCF@Film. This bioscaffold is engineered to direct cell growth while serving as an efficient platform for photodynamic antibacterial therapy (PDAT) under near-infrared (NIR) light. The alignment of fibers not only mimics natural tissue architecture, enhancing cellular orientation and growth, but also provides mechanical strength and hemocompatibility. Critically, the covalent conjugation of the Ce6 photosensitizer ensures its retention and functionality within the scaffold, overcoming the rapid systemic clearance and potential cytotoxicity of free molecular agents.

Methods and Experimental Design Insights

The researchers employed a multi-step fabrication workflow. Silk fibroin was first extracted and purified, then functionalized with Ce6 via chemical conjugation. Electrospinning was used to form aligned nanofiber mats, which were then laminated onto a silk fibroin film substrate. This composite structure (SFCF@Film) was characterized using scanning electron microscopy (SEM) for morphological analysis, and its mechanical properties were quantified through tensile testing. Hemocompatibility was assessed by red blood cell interaction assays.

Functional assays focused on the PDAT mechanism: under NIR irradiation, the SFCF@Film's ability to generate reactive oxygen species (ROS) was quantified, as ROS are central to photodynamic cytotoxicity. Antibacterial efficacy was tested against S. aureus, both planktonic and biofilm forms, in vitro and in a murine wound infection model. The study also evaluated immunomodulatory effects by examining macrophage polarization markers, particularly the promotion of M2 (pro-healing) phenotype during wound resolution.

Core Findings and Why They Matter

The SFCF@Film demonstrated several key outcomes (Li et al., 2024):

• Guided Cell Growth: The aligned fiber architecture facilitated directional cell migration and proliferation, supporting tissue regeneration.
• Robust Photodynamic Antibacterial Action: Upon NIR irradiation, the Ce6 conjugated within the scaffold rapidly generated ROS, resulting in near-complete eradication of S. aureus in both planktonic and biofilm forms within 10 minutes. This highlights the scaffold's capacity for efficient reactive oxygen species generation, a hallmark of advanced photodynamic therapy photosensitizers.
• Biofilm Disruption: The system successfully penetrated and disrupted established bacterial biofilms, a major barrier to effective infection control in chronic wounds.
• In Vivo Wound Healing Enhancement: In a murine model, SFCF@Film reduced bacterial burden and accelerated wound closure compared to controls. Notably, the material also promoted M2 macrophage polarization, which is associated with resolution of inflammation and enhanced tissue repair.
• Biocompatibility and Hemocompatibility: The scaffold exhibited minimal hemolytic activity and did not provoke adverse tissue reactions, supporting its translational potential.

These findings are significant for the field of wound healing and antibacterial biomaterials, providing evidence that the integration of Ce6 photosensitizer into biocompatible scaffolds can overcome the dual challenges of infection and impaired tissue repair.

Comparison with Existing Internal Articles

Several recent reviews and studies have explored the integration of Chlorin e6 into various biomaterial platforms for both anticancer and antibacterial photodynamic therapy. For instance, the article "Silk Fibroin–Ce6 Electrospun Films Enable Antibacterial Photodynamic Therapy" discusses similar approaches, emphasizing rapid ROS generation and biofilm elimination in antibiotic-resistant infections. Li et al.'s work extends these findings by providing rigorous in vivo evidence for both antibacterial efficacy and immunomodulatory effects in wound healing.

Other internal analyses, such as "Chlorin e6 Photosensitizer in Anticancer and Antibacterial PDT", highlight the versatility of Ce6 across oncology and infectious disease, while "Chlorin e6 (Ce6): Mechanistic Insights and Clinical Potential in Photodynamic Therapy" delve into the molecular mechanisms of ROS generation and workflow considerations. The present study advances the field by demonstrating that immobilized Ce6 within a tissue-mimetic scaffold retains high photodynamic activity, with practical implications for wound management where systemic photosensitizer delivery may be suboptimal or unsafe.

Limitations and Transferability

While the SFCF@Film system exhibits strong preclinical efficacy, several limitations must be acknowledged:

• Model Specificity: The in vivo studies were conducted in a murine model, which, while informative, may not fully recapitulate the complexity of human wound healing and infection dynamics.
• Light Penetration Depth: Photodynamic therapy's dependence on external irradiation requires careful consideration of wound depth and accessibility. NIR wavelengths offer improved tissue penetration, but application in deep or irregular wounds may be constrained.
• Scaffold Degradation and Long-term Safety: The long-term fate of the scaffold and the potential for chronic inflammatory responses, especially in immune-compromised settings, require further exploration prior to clinical translation.
• Ce6 Release Kinetics: Although covalent conjugation reduces systemic release, potential leaching and the effects on local tissue must be systematically assessed in future studies.

Nevertheless, the experimental design and results provide a robust platform for further translational research, including optimization of photosensitizer loading, scaffold architecture, and irradiation protocols for human application.

Protocol Parameters

• Ce6 Conjugation: Covalently attach Ce6 to silk fibroin using EDC/NHS chemistry under mild aqueous conditions to preserve both protein structure and photosensitizer activity.
• Electrospinning: Prepare 8–12 wt% silk fibroin–Ce6 solution and electrospin at 15–20 kV with a tip-to-collector distance of 12–18 cm to achieve uniform, aligned nanofibers.
• Photodynamic Activation: Apply NIR light at 660–670 nm, with an irradiation dose ranging from 50–200 J/cm², for up to 10 minutes to induce rapid ROS generation and antibacterial effects.
• In Vivo Infection Model: Create full-thickness excisional wounds in mice and inoculate with 10⁷ CFU S. aureus; cover with SFCF@Film and apply NIR irradiation daily for optimal results.

Research Support Resources

Researchers interested in replicating or extending this workflow can utilize Chlorin e6 (Ce6) (SKU B8314), a well-characterized photosensitizer with documented efficacy in both anticancer and antibacterial photodynamic therapy. Ce6 is soluble up to 30 mg/mL in DMSO and is supplied with comprehensive quality control data, making it suitable for conjugation with biopolymers and evaluation in similar experimental settings. For further mechanistic insights and protocol adaptations, see the internal review "Chlorin e6 (Ce6): Mechanistic Insights and Clinical Potential in Photodynamic Therapy".